Visit link:
SciSparc Issued Israeli Patent for its Core Technology for Treating Central Nervous Systems Disorders
New Analysis of SOLOIST-WHF Trial Underscores Sotagliflozin’s Effect on Reducing Recurrent Heart Failure Events
Go here to see the original:
New Analysis of SOLOIST-WHF Trial Underscores Sotagliflozin’s Effect on Reducing Recurrent Heart Failure Events
Israel-Based Clearmind Announces Additional Positive Results from the Third Part of its Pre-Clinical Study for Cocaine Addiction Treatment
MacroGenics Earns $15 Million Milestone Following U.S. FDA Approval of ZYNYZ™ (retifanlimab-dlwr)
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
See the rest here:
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Bavarian Nordic Enters Agreement Valued up to USD 83 Million with the U.S. Department of Defense to Further Advance the Development of Equine…
Read more from the original source:
Bavarian Nordic Enters Agreement Valued up to USD 83 Million with the U.S. Department of Defense to Further Advance the Development of Equine...
Syncona Commences Tender Offer for All Outstanding Shares of Applied Genetic Technologies Corporation
NKGen Biotech Announces Collaboration with the Parkinson’s Foundation to Bring Its Novel Natural Killer Cell Therapy to the Clinic for Advanced…
Lexicon Pharmaceuticals to Host Third Quarter 2022 Financial Results Conference Call and Webcast on November 9, 2022
Belite Bio Presented 12-Month Interim Results of LBS-008 Phase 1b/2 Study in Adolescent Stargardt Disease at AAO Annual Meeting 2022
Apellis Announces 24-Month Phase 3 Post Hoc Results Showing Treatment with Pegcetacoplan Led to Preservation of Function in High-Risk Areas of the…
Mesoblast Submits New Information to FDA IND File in Response to Items in the CRL to the Remestemcel-L BLA for SR-aGVHD
Myovant Sciences Special Committee of Board Confirms Receipt of Preliminary, Non-binding Proposal from Sumitovant Biopharma and Sumitomo Pharma to…
Bavarian Nordic Enters Agreement with Country in Latin America on the Supply of Monkeypox Vaccines
Go here to read the rest:
Bavarian Nordic Enters Agreement with Country in Latin America on the Supply of Monkeypox Vaccines
Idorsia Japan announces positive results with daridorexant in a Phase 3 study of Japanese patients with insomnia
IN8bio Reports Second Quarter 2022 Financial Results and Provides Corporate Update
Relief Therapeutics and Acer Therapeutics Announce that the European Commission Has Granted Orphan Drug Designation for ACER-001 in Maple Syrup Urine…
Tiziana Life Sciences Ltd. Receives Nasdaq Deficiency Notice
See the original post here:
Tiziana Life Sciences Ltd. Receives Nasdaq Deficiency Notice